Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs episode artwork

EPISODE · Sep 16, 2022 · 30 MIN

Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs

from Investors' Chronicle

On this week's Companies and Markets show, the team discuss a reality check for hydrogen hope ITM Power (ITM), whose annual results sparked a steep sell-off in the company’s shares on Wednesday.Economics writer Hermione Taylor then outlines the debate over ‘Trussonomics’, looking at government policies and their potential impact on the UK economy, sterling, and the gilt market.Last but not least, Jennifer Johnson runs the rule over latest figures from Advanced Medical Solutions (AMS) and Abcam (ABC), as well as the latter’s plans to delist from Aim.Dan Jones hosts Julian Hofmann, Hermione Taylor, Jennifer Johnson and Alex Newman.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Sep 16, 2022

Embed this episode

Ready to play

Companies & Markets Show: ITM Power, Trussonomics and the challenges for UK healthcare and biotechs

0:00 30:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Investors' Chronicle?

This episode is 30 minutes long.

When was this Investors' Chronicle episode published?

This episode was published on September 16, 2022.

Can I download this Investors' Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!